The Research based on MRI to investigate the role of tVNS in regulate inflammation and reward loops in Recurrent MDD Patients

注册号:

Registration number:

ITMCTR1900002288

最近更新日期:

Date of Last Refreshed on:

2019-04-19

注册时间:

Date of Registration:

2019-04-19

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

耳电针调节炎症参与的抑郁症奖赏环路的磁共振研究

Public title:

The Research based on MRI to investigate the role of tVNS in regulate inflammation and reward loops in Recurrent MDD Patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

耳电针调节炎症参与的抑郁症奖赏环路的磁共振研究

Scientific title:

The Research based on MRI to investigate the role of tVNS in regulate inflammation and reward loops in Recurrent MDD Patients

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900022618 ; ChiMCTR1900002288

申请注册联系人:

王晓旭

研究负责人:

刘春红

Applicant:

Wang Xiaoxu

Study leader:

Liu Chunhong

申请注册联系人电话:

Applicant telephone:

+86 13693162697

研究负责人电话:

Study leader's telephone:

+86 13693384531

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xxw950912@163.com

研究负责人电子邮件:

Study leader's E-mail:

chunhongliu11@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市东城区美术馆后街23号

研究负责人通讯地址:

北京市东城区美术馆后街23号

Applicant address:

23 Art Museum Back Street, Dongcheng District, Beijing

Study leader's address:

23 Art Museum Back Street, Dongcheng District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京中医医院

Applicant's institution:

Beijing Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2018BL-076-02

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

首都医科大学附属北京中医医院伦理委员会

Name of the ethic committee:

EC of Beijing Hospital of Traditional Chinese Medicine to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2019/1/18 0:00:00

伦理委员会联系人:

王晶

Contact Name of the ethic committee:

Wang Jing

伦理委员会联系地址:

北京市东城区美术馆后街12号,空达维尔515室

Contact Address of the ethic committee:

Room 515, Kundawell Medical Institute, 12 Art Museum Back Street, Dongcheng District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京中医医院

Primary sponsor:

Beijing Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

北京市东城区美术馆后街23号

Primary sponsor's address:

23 Art Museum Back Street, Dongcheng District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

BeiJing

City:

单位(医院):

首都医科大学附属北京中医医院

具体地址:

东城区美术馆后街23号

Institution
hospital:

Beijing Hospital of Traditional Chinese Medicine

Address:

23 Art Museum Back Street, Dongcheng District

经费或物资来源:

国家自然科学基金

Source(s) of funding:

National Nature Science Foundation

研究疾病:

抑郁症

研究疾病代码:

Target disease:

major depressive disorder

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

⑴明确taVNS治疗缓解期MDD,预防复发的效果。 ⑵比较taVNS组和假taVNS组6个月治疗前后缓解期MDD患者的多模态磁共振的改变,探讨taVNS调节MDD的神经环路。 ⑶比较taVNS组和假taVNS组治疗6月前后及随访1年后的激素水平和炎症标志物随时间的变化,并与脑影像指标做相关分析,探讨taVNS对炎症的改善及与脑功能改变的相关性。

Objectives of Study:

To investigate the effect of taVNS in the treatment of remission MDD and prevent recurrence. To compare alterations in MRI between taVNS group and sham taVNS group before and after 6 month treatment. To compare alterations in hormonal levels and inflammatory markers over time between taVNS group and sham-taVNS group before and after 6 month treatment and 1 year follow-up.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

① MDD诊断采用DSM-IV轴I精神障碍定式临床访谈(Structured Clinical Interview for DSM-IV Axis I Disorders,SCID-I/P)进行评估,据DSM-IV诊断标准确诊MDD; ② 年龄在18-60岁之间; ③ HAMD≤7分以及焦虑量表(Hamilton Anxiety Scale,HAMA)≤7分(持续两周以上); ④ 文化程度为初中以上; ⑤ 右利手,符合中国人利手量表(Chinese Hand Preference Questionnaire,CHPQ)标准; ⑥ 自愿参加,签署知情同意书。

Inclusion criteria

(1) ICD-10 diagnosis standard of a depressive episode; (2) Aged 18 and 60 years; (3) Hamilton Anxiety ScaleHAMA≤7 Meets; (4) Junior high or higher level education; (5) Right-handed; (6) Signing informed consent.

排除标准:

① 妊娠期和哺乳期妇女; ② 最近一个月内接受过无抽搐电休克治疗、抗精神病或抗抑郁药物治疗; ③ 存在自杀观念或有自杀行为者;严重的兴奋、冲动不合作的患者; ④ 有药物成瘾史; ⑤ 体内有金属异物(如金属假牙、心脏起搏器等)影响磁共振检查者。

Exclusion criteria:

(1) Ongoing addiction to drugs and alcohol; (2) Organic mental disorder; (3) Drug-induced depression; (4) Pregnant women; (5) Postpartum depression.

研究实施时间:

Study execute time:

From 2019-01-01

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2019-06-01

To      2020-12-31

干预措施:

Interventions:

组别:

假taVNS组

样本量:

45

Group:

sham taVNS

Sample size:

干预措施:

双侧耳廓外耳缘中部表皮迷走神经电刺激

干预措施代码:

Intervention:

sham transcutaneous auricular vagus nerve stimulation

Intervention code:

组别:

taVNS组

样本量:

45

Group:

taVNS

Sample size:

干预措施:

双侧耳甲部及外耳道表皮迷走神经电刺激

干预措施代码:

Intervention:

transcutaneous auricular vagus nerve stimulation

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院广安门医院

单位级别:

三级甲等

Institution/hospital:

Guang'anmen Hospital China Academy of Chinese Medical Science

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京中医医院

单位级别:

三级甲等

Institution/hospital:

Beijing Hospital of Traditional Chinese Medicine of Capital Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院

单位级别:

三级甲等

Institution/hospital:

BeiJing Anding Hospital Capital Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

炎症标志物

指标类型:

主要指标

Outcome:

Inflammatory marker

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

激素水平

指标类型:

主要指标

Outcome:

Hormone level

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

多模态磁共振

指标类型:

主要指标

Outcome:

resting-state functional magnetic resonance imaging

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 60
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

招募人员由随机数字表法产生随机数字。

Randomization Procedure (please state who generates the random number sequence and by what method):

Recruiters generate random numbers from random number tables.

盲法:

对患者和疗效评价者施行盲法

Blinding:

Blind method for patients and therapeutic effect evaluator.

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://www.bjzhongyi.com/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.bjzhongyi.com/

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表 电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form Electronic Data Capture

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above